- Northstrive Biosciences and Yuva Biosciences’ collaboration will leverage MitoNova™, YuvaBio’s proprietary mitochondrial science-focused artificial intelligence platform, to discover and develop novel pharmaceutical treatments for obesity, type 2 diabetes and other cardiometabolic conditions.
- Northstrive and Yuva Biosciences will compile a library of small molecule candidates that promote mitochondrial health and target the root cause of aging at the cellular level.
NEWPORT BEACH,…
Article Source
https://www.globenewswire.com/news-release/2025/04/10/3059185/0/en/Northstrive-Biosciences-Signs-Partnership-with-Yuva-Biosciences-to-Develop-AI-Powered-Therapies-for-Obesity-and-Cardiometabolic-Diseases.html
